Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Innocan Pharma Corp. buy Heisinger

Start price
€0.89
17.09.21 / 50%
Target price
-
17.09.22
Performance (%)
-55.14%
End price
€0.40
19.05.22
Summary
This prediction ended on 19.05.22 with a price of €0.40. The BUY prediction by Heisinger for Innocan Pharma Corp. performed very badly with a performance of -55.14%. Heisinger has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Innocan Pharma Corp. - - -
iShares Core DAX® 0.597% 3.083% 16.090%
iShares Nasdaq 100 0.899% 5.338% 29.239%
iShares Nikkei 225® 1.775% -1.206% 6.823%
iShares S&P 500 0.990% 3.500% 24.956%

Comments by Heisinger for this prediction

In the thread Innocan Pharma Corp. diskutieren

Buy Innocan Pharma Corp.